Home » Stocks » CPIX

Cumberland Pharmaceuticals, Inc. (CPIX)

Stock Price: $3.26 USD -0.04 (-1.21%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $3.25 -0.01 (-0.31%) Jul 23, 7:24 PM
Market Cap 49.06M
Revenue (ttm) 39.65M
Net Income (ttm) -2.12M
Shares Out 15.05M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $3.26
Previous Close $3.30
Change ($) -0.04
Change (%) -1.21%
Day's Open 3.31
Day's Range 3.26 - 3.33
Day's Volume 18,361
52-Week Range 2.58 - 3.94

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed last week his firm made changes to its portfolio on June 30.

Other stocks mentioned: BIDU, GLAE, MIND, MSFT, MSGE, PM
1 week ago - GuruFocus

4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness

Other stocks mentioned: ACER, ORGO, XNCR
1 month ago - Zacks Investment Research

NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of...

1 month ago - PRNewsWire

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

1 month ago - Zacks Investment Research

NASHVILLE, Tenn., May 19, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to  Director Finance & A...

2 months ago - PRNewsWire

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which b...

2 months ago - Benzinga

NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial re...

2 months ago - PRNewsWire

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, May 11. Here is Benzinga's look at Cumberland's Q1 earnings report.

2 months ago - Benzinga

NASHVILLE, Tenn., May 4, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2021 financial results and Company update after the market...

2 months ago - PRNewsWire

Seattle-based Tegria, a healthcare services and tech company that Providence launched last year, announced the acquisition of Franklin, Tenn.

4 months ago - GeekWire

Cumberland (CPIX) delivered earnings and revenue surprises of 200.00% and 4.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 88.89% over the past year to $0.01, which beat th...

4 months ago - Benzinga

NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, toda...

4 months ago - PRNewsWire

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's look at Cumberland's Q4 earnings report.

4 months ago - Benzinga

NASHVILLE, Tenn., March 2, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2020 financial results and Company update af...

4 months ago - PRNewsWire

NASHVILLE, Tenn., Nov. 17, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, announced today the launch of RediTrex® (methotrexate) injection....

8 months ago - PRNewsWire

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Shares of Cumberland (NASDAQ:CPIX) were flat after the company reported Q3 results. Quarterly Results Earnings per share increased 100.00% over the past year to $0.02, which beat the estimate of ($0.07).

8 months ago - Benzinga

NASHVILLE, Tenn., Nov. 10, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and third quarter 2020 financial r...

8 months ago - PRNewsWire

Cumberland (NASDAQ: CPIX) unveils its next round of earnings this Tuesday, November 10. Get prepared with Benzinga's ultimate preview for Cumberland's Q3 earnings.

8 months ago - Benzinga

NASHVILLE, Tenn., Nov. 3, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2020 financial results and Company update after the marke...

8 months ago - PRNewsWire

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

ATLANTA, Sept. 28, 2020 /PRNewswire/ -- Women's apparel and fashion accessories retailer, Charming Charlie, today announced that it will open its first physical store at the Cumberland Mall in Atlanta, ...

9 months ago - PRNewsWire

SAN JOSE, Calif.--(BUSINESS WIRE)---- $CALX #Calix--Cumberland Connect is deploying FTTH with Calix and has completed an end-to-end network integration 83 percent faster than industry standards

10 months ago - Business Wire

NASHVILLE, Tenn., Aug. 18, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

11 months ago - PRNewsWire

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A.

11 months ago - Seeking Alpha

Cumberland (CPIX) delivered earnings and revenue surprises of 166.67% and 3.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

Shares of Cumberland (NASDAQ:CPIX) rose 2.07% in after-market trading after the company reported Q2 results.

11 months ago - Benzinga

NASHVILLE, Tenn., Aug. 11, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

11 months ago - PRNewsWire

Cumberland (NASDAQ: CPIX) releases its next round of earnings this Tuesday, August 11.

11 months ago - Benzinga

NASHVILLE, Tenn., Aug. 4, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

11 months ago - PRNewsWire

NASHVILLE, Tenn., July 20, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

1 year ago - PRNewsWire

Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 year ago - Zacks Investment Research

NASHVILLE, Tenn., May 26, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, announces a new publication in Drugs - Real World Outcomes1, detai...

1 year ago - PRNewsWire

Cumberland (CPIX) delivered earnings and revenue surprises of -50.00% and -11.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

NASHVILLE, Tenn., May 20, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a com...

1 year ago - PRNewsWire

Here are four top-ranked liquid gems that investors can add to portfolio for remarkable returns.

Other stocks mentioned: EXPI, MED, NPTN
1 year ago - Zacks Investment Research

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.

Other stocks mentioned: AMAG, MIST
1 year ago - Zacks Investment Research

In a volatile market, it's more important than ever to hone your technical analysis skills. Here are some near-term trading ideas.

Other stocks mentioned: ALIM, OSG, RRTS, TTNP
1 year ago - Investopedia

Cumberland Pharmaceuticals Inc (CPIX) CEO A. J. Kazimi on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Cumberland (CPIX) delivered earnings and revenue surprises of 800.00% and 20.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Cumberland Pharmaceuticals' (CPIX) CEO A. J. Kazimi on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Cumberland (CPIX) delivered earnings and revenue surprises of -90.91% and -18.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Cumberland Pharmaceuticals (CPIX) closed at $5.56 in the latest trading session, marking a -0.18% move from the prior day.

1 year ago - Zacks Investment Research

Cumberland Pharmaceuticals' (CPIX) third-quarter results are expected to reflect solid sales growth.

1 year ago - Zacks Investment Research

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Cumberland Pharmaceuticals (CPIX) closed at $5.34 in the latest trading session, marking a +0.75% move from the prior day.

1 year ago - Zacks Investment Research

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylo... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Aug 11, 2009
Stock Exchange
NASDAQ
Ticker Symbol
CPIX
Full Company Profile

Financial Performance

In 2020, CPIX's revenue was $37.44 million, an increase of 8.88% compared to the previous year's $34.39 million. Losses were -$3.34 million, -5.61% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for CPIX stock is "Strong Buy" and the 12-month stock price forecast is 8.50.

Price Target
$8.50
Analyst Consensus: Strong Buy